The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Persistent Methicillin-resistant Staphylococcus aureus and Rate of FEV 1 Decline in Cystic Fibrosis
Abstract
RATIONALE: The prevalence in cystic fibrosis (CF) of respiratory cultures with methicillin-resistant Staphylococcus aureus (MRSA) has dramatically increased over the last 10 years, but the effect of MRSA on FEV(1) decline in CF is unknown. OBJECTIVES: To determine the association between MRSA respiratory infection and FEV(1) decline in children and adults with CF. METHODS: This was a 10-year cohort study using the Cystic Fibrosis Foundation patient registry from 1996-2005. We studied individuals who developed new MRSA respiratory tract infection. Repeated-measures regression was used to assess the association between MRSA and FEV(1) decline, adjusted for confounders, in individuals aged 8-21 years and adults (aged 22-45 yr). Two different statistical models were used to assess robustness of results. MEASUREMENTS AND MAIN RESULTS: The study cohort included 17,357 patients with an average follow-up of 5.3 years. During the study period, 1,732 individuals developed new persistent MRSA infection (> or =3 MRSA cultures; average, 6.8 positive cultures) and were subsequently followed for an average of 3.5 years. Even after adjustment for confounders, rate of FEV(1) decline in individuals aged 8-21 years with persistent MRSA was more rapid in both statistical models. Their average FEV(1) decline of 2.06% predicted/year was 43% more rapid than the 1.44% predicted/year in those without MRSA (difference, -0.62% predicted/yr; 95% confidence interval, -0.70 to -0.54; P < 0.001). Effect of MRSA on FEV(1) decline in adults was not clinically significant. CONCLUSIONS: Persistent infection with MRSA in individuals with CF between the ages of 8 and 21 years is associated with a more rapid rate of decline in lung function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Longitudinal Data Analysis for Discrete and Continuous Outcomes
Zeger, S. L., & Liang, K.-Y. (1986) · Biometrics · doi:10.2307/2531248 · Cited by 7,764
Webb, A. K. (2006) · Cited by 4,369
Spirometric Reference Values from a Sample of the General U.S. Population
HANKINSON, J. L., ODENCRANTZ, J. R., & FEDAN, K. B. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.1.9712108 · Cited by 4,206
Cosgrove, S. E., Sakoulas, G., Perencevich, E. N., Schwaber, M. J., Karchmer, A. W., & Carmeli, Y. (2003) · Clinical Infectious Diseases · doi:10.1086/345476 · Cited by 1,964
Immune evasion by staphylococci
Foster, T. J. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1289 · Cited by 1,222
The changing epidemiology of cystic fibrosis
FitzSimmons, S. C. (1993) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)83478-x · Cited by 928
Effect of High-Dose Ibuprofen in Patients with Cystic Fibrosis
Konstan, M. W., Byard, P. J., Hoppel, C. L., & Davis, P. B. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503303321303 · Cited by 726
Pulmonary function between 6 and 18 years of age
Wang, X., Dockery, D. W., Wypij, D., Fay, M. E., & Ferris, B. G. (1993) · Pediatric Pulmonology · doi:10.1002/ppul.1950150204 · Cited by 648
Diagnosis, screening and management of cystic fibrosis related diabetes mellitus
Moran, A., Hardin, D., Rodman, D., Allen, H. F., Beall, R. J., Borowitz, D., Brunzell, C., Campbell III, P. W., Chesrown, S. E., Duchow, C., et al. (1999) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(99)00058-3 · Cited by 293
Risk of Infection and Death due to Methicillin‐Resistant Staphylococcus aureus in Long‐Term Carriers
Datta, R., & Huang, S. S. (2008) · Clinical Infectious Diseases · doi:10.1086/589241 · Cited by 222
Risk of death in cystic fibrosis patients with severely compromised lung function
Milla, C. E., & Warwick, W. J. (1998) · Chest · doi:10.1378/chest.113.5.1230 · Cited by 167
Late Diagnosis Defines a Unique Population of Long-term Survivors of Cystic Fibrosis
Rodman, D. M., Polis, J. M., Heltshe, S. L., Sontag, M. K., Chacon, C., Rodman, R. V., Brayshaw, S. J., Huitt, G. A., Iseman, M. D., Saavedra, M. T., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200403-404oc · Cited by 160
Ren, C., Morgan, W. J., Konstan, M., Schechter, M. S., Wagener, J. S., Fisher, K. A., & Regelmann, W. (2007) · Pediatric Pulmonology · doi:10.1002/ppul.20604 · Cited by 159
Rosenstein, B. J., & Zeitlin, P. L. (1998) · The Lancet · doi:10.1016/s0140-6736(97)09174-5 · Cited by 159
Prospective evaluation of emerging bacteria in cystic fibrosis
Steinkamp, G., Wiedemann, B., Rietschel, E., Krahl, A., Gielen, J., Bärmeier, H., & Ratjen, F. A. (2005) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2004.10.002 · Cited by 114
Elizur, A., Orscheln, R. C., Ferkol, T. W., Atkinson, J. J., Dunne, W. M., Buller, R. S., Armstrong, J. R., Mardis, E. R., Storch, G. A., & Cannon, C. L. (2007) · CHEST Journal · doi:10.1378/chest.06-2756 · Cited by 88
Glikman, D., Siegel, J. D., David, M. Z., Okoro, N., Boyle‐Vavra, S., Dowell, M. L., & Daum, R. S. (2008) · CHEST Journal · doi:10.1378/chest.07-2437 · Cited by 82
Stone, A., & Saiman, L. M. (2007) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e3282efbbac · Cited by 61
Boxerbaum, B., Jacobs, M. R., & Cechner, R. L. (1988) · Pediatric Pulmonology · doi:10.1002/ppul.1950040307 · Cited by 54
Zhou, J. J., Garber, E., Desai, M., & Saiman, L. M. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.4.1547-1549.2006 · Cited by 44
Campana, S., Cocchi, P., Döring, G., & Taccetti, G. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00132-07 · Cited by 21
Cited by
Update on Key Emerging Challenges in Cystic Fibrosis
Jennings, M. T., Riekert, K. A., & Boyle, M. P. (2014) · Medical Principles and Practice · doi:10.1159/000357646 · Cited by 3,648
Self-citationDavid, M. Z., & Daum, R. S. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00081-09 · Cited by 1,972
Community-associated meticillin-resistant Staphylococcus aureus
DeLeo, F. R., Otto, M., Kreiswirth, B. N., & Chambers, H. F. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61999-1 · Cited by 1,506
O'Sullivan, B. P., & Freedman, S. D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60327-5 · Cited by 1,320
Failure to Recover to Baseline Pulmonary Function after Cystic Fibrosis Pulmonary Exacerbation
Sanders, D. B., Bittner, R. C. L., Rosenfeld, M., Hoffman, L. R., Redding, G. J., & Goss, C. H. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200909-1421oc · Cited by 519
Metadata
- Authors
- Dasenbrook, E. C., Merlo, C. A., Diener-West, M., Lechtzin, N., & Boyle, M. P.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-10-15
- Volume
- 178
- Issue
- 8
- Pages
- 814-821
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2105534700
- Cited by
- 319
- References
- 21
- FWCI
- 19.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.